Mount Logan Capital (MLCI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
29 Apr, 2026Executive summary
Annual Meeting scheduled for June 25, 2026, with voting open until June 24, 2026, at 11:59 PM ET.
Shareholders can access proxy materials online or request paper/email copies by June 11, 2026.
Meeting will be held virtually, allowing remote participation and voting.
Voting matters and shareholder proposals
Election of two Class I directors, Parker A. Weil and Matthew Westwood, to serve until the 2029 Annual Meeting.
Ratification of Deloitte & Touche LLP as independent registered public accountant for fiscal year ending December 31, 2026.
Board recommends voting in favor of all proposals.
Other business may be addressed if properly brought before the meeting.
Board of directors and corporate governance
Two director nominees are up for election, each to serve a three-year term until 2029.
Latest events from Mount Logan Capital
- Fee and spread-related earnings surged year-over-year, despite a net loss.MLCI
Q3 20248 Jul 2026 - Director elections and auditor ratification passed; no further business or questions raised.MLCI
AGM 202625 Jun 2026 - Synergistic asset management and insurance platform drives growth and remains undervalued.MLCI
Planet MicroCap Las Vegas 202617 Jun 2026 - Segment income up 41% YoY, SRE and FRE improved, with major asset and insurance growth initiatives.MLCI
Q1 202615 May 2026 - Transformative year with Nasdaq listing, asset growth, and new fee streams despite a net loss.MLCI
Q4 202515 May 2026 - Annual meeting to elect directors and ratify auditor, with strong governance and oversight.MLCI
Proxy filing30 Apr 2026 - Annual Meeting to elect directors and ratify auditor, with strong governance and oversight.MLCI
Proxy filing29 Apr 2026 - Fee-related earnings up 28% YoY; merger approved, expected to drive future growth.MLCI
Q2 20255 Feb 2026 - Q3 2025 saw a major merger, higher net loss, strong liquidity, and first shareholder dividend.MLCI
Q3 20255 Feb 2026